Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils

Blood

Volumn 89, Issue 11, 1997, Pages 4175-4181

  Watson, R William G ^a   Rotstein, Ori D ^a   Jimenez, Maria ^a   Parodo, Jean ^a   Marshall, John C ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BACTERIUM LIPOPOLYSACCHARIDE; BUTHIONINE SULFOXIMINE; CELL ADHESION MOLECULE; FAS ANTIGEN; GLUTATHIONE; INTEGRIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURFACE; CELL SURVIVAL; CROSS LINKING; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL;

EID: 1842333923     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.11.4175     Document Type: Article

References (41)

1. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
2. Suda T, Nagata S: Purification and characterization of the Fasligand that induces apoptosis. J Exp Med 179:873, 1994
3. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505, 1995
4. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MOR1/FADD-interacting protease, in Fas/ APO-1-and TNF receptor-induced cell death. Cell 85:803, 1996
5. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME. Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85:817, 1996
6. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin T, Nicholson DW: CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841, 1996
7. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189, 1995
8. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
9. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 83:639, 1992
10. Liles WC, Klebanoff SJ: Regulation of apoptosis in neutrophils - Fas Track to Death? J Immunol 155:3289, 1995
11. Lee A, Whyte MKB, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leuk Biol 54:283, 1993
12. Yamamoto C, Yoshida S, Taniguchi H, Qin MH, Miyamoto H, Mizuguchi Y: Lipopolysaccharide and granulocyte colony stimu. lating factor delay neutrophil apoptosis and ingestion by guinea pig macrophages, infect Immun 61:1972, 1993
13. Armant M, Delespesse G, Sarfati M: IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and Upregulate bcl-2 expression. Immunology 85:331, 1995
14. Watson RWG, Rotstein OD, Nathens AB, Marshall JC: Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol 158:945, 1997
15. Watson RWG, Redmond HP, Wang JH, Condron C, Bouchier-Hays D: Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 156:3986, 1996
16. Mangan EF, Robertson B, Wahl SM: 1L-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 148:1812, 1992
17. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF, Schuhe-Hermann R: Transforming growth factor-1 as a signal for induction of cell death by apoptosis. Br J Cancer 67:531, 1993
18. Woods KM, Chapes SK: Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis. J Leuk Biol 53:37, 1993
19. Crispe IN: Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347, 1994.
20. Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M: Fasmediated apoptosis in cultured human eosinophils. Blood 87:2822, 1996
21. Um H, Orenstein JM, Wahl SM: Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156:3469, 1996
22. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
23. Smith JA, Weidemann MJ: Further characterization of neutrophil oxidative burst by flow cytometry. J Immunol Methods 162:261, 1993
24. Allen RC: Phagocytic leukocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis. Methods Enzymol 133:449, 1986
25. Jocelyn PC: Spectrophotometric assay of thiols. Methods Enzymol 143:44, 1987
26. Watson RWG, Rotstein OD, Nathens AB, Dackiw APB, Marshall JC: Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 120:150, 1996
27. Clement M, Stamenkovic I: Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J 15:216, 1996
28. Droge W, Eck HP, Mihms: HIV-induced cysteine deficiency and T-cell dysfunction-a rational for treatment for N-acetylcysteine. Immunol Today 13:472, 1992
29. Griffith OW: Mechanisms of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione biosynthesis. J Biol Chem 257:13704, 1982
30. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell 81:495, 1995
31. Rensing-Ehl A, Hess S, Ziegler-Heitbrock HW, Riethmulier G, Engelmann H: Fas/APO-1 activates nuclear factor kappa B and enhances interleukin-6 production. J Inflamm 45:161, 1995
32. Schulze-Osthoff K, Krammer PH, Droge W: Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J 13:4587, 1994.
33. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068, 1995
34. Rosales C, Juliano RL: Signal transduction by cell adhesion receptors in leukocytes. J Leuk Biol 57:189, 1995
35. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891, 1995
36. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201, 1994
37. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J Exp Med 184:429, 1996
38. Kohno T, Yamada Y, Hata T, Mori H, Yamamura M, Tomonaga M, Urata Y, Goto S, Kondo T: Relation of oxidative stress and glutathione synthesis to CD95 (Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J Immunol 154:4722, 1995
39. Nagata S, Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39, 1995
40. Mountz JD, Baker TJ, Borcherding DR, Bluethmann H, Zhou T, Edwards CK: Increased susceptibility of fas mutant MRL-lpr/ lpr mice to Staphylococcal enterotoxin B-induced septic shock. J Immunol 155:4829, 1995
41. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature 364:806, 1993